Cyduct Diagnostics Pink Sheet Forecast - Naive Prediction
| CYDX Stock | USD 1.60 1.10 40.74% |
Cyduct Pink Sheet outlook is based on your current time horizon.
The relative strength index (RSI) of Cyduct Diagnostics' pink sheet price is slightly above 61 suggesting that the pink sheet is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Cyduct, making its price go up or down. Momentum 61
Buy Extended
Oversold | Overbought |
Using Cyduct Diagnostics hype-based prediction, you can estimate the value of Cyduct Diagnostics from the perspective of Cyduct Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Cyduct Diagnostics on the next trading day is expected to be 1.96 with a mean absolute deviation of 0.26 and the sum of the absolute errors of 15.85. Cyduct Diagnostics after-hype prediction price | USD 1.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cyduct |
Cyduct Diagnostics Additional Predictive Modules
Most predictive techniques to examine Cyduct price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyduct using various technical indicators. When you analyze Cyduct charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cyduct Diagnostics Naive Prediction Price Forecast For the 28th of January
Given 90 days horizon, the Naive Prediction forecasted value of Cyduct Diagnostics on the next trading day is expected to be 1.96 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.11, and the sum of the absolute errors of 15.85.Please note that although there have been many attempts to predict Cyduct Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cyduct Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cyduct Diagnostics Pink Sheet Forecast Pattern
| Backtest Cyduct Diagnostics | Cyduct Diagnostics Price Prediction | Buy or Sell Advice |
Cyduct Diagnostics Forecasted Value
In the context of forecasting Cyduct Diagnostics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cyduct Diagnostics' downside and upside margins for the forecasting period are 0.02 and 53.28, respectively. We have considered Cyduct Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cyduct Diagnostics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Cyduct Diagnostics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.7427 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2556 |
| MAPE | Mean absolute percentage error | 0.8861 |
| SAE | Sum of the absolute errors | 15.8481 |
Predictive Modules for Cyduct Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyduct Diagnostics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyduct Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyduct Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Cyduct Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyduct Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Cyduct Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cyduct Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Cyduct Diagnostics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyduct Diagnostics' historical news coverage. Cyduct Diagnostics' after-hype downside and upside margins for the prediction period are 0.08 and 161.60, respectively. We have considered Cyduct Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cyduct Diagnostics is out of control at this time. Analysis and calculation of next after-hype price of Cyduct Diagnostics is based on 3 months time horizon.
Cyduct Diagnostics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cyduct Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyduct Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyduct Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
7.60 | 51.32 | 0.00 | 0.68 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.60 | 1.60 | 0.00 |
|
Cyduct Diagnostics Hype Timeline
Cyduct Diagnostics is currently traded for 1.60. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.68. Cyduct is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 7.6%. %. The volatility of related hype on Cyduct Diagnostics is about 57604.67%, with the expected price after the next announcement by competition of 0.92. The company last dividend was issued on the 1st of December 2020. Cyduct Diagnostics had 1:250 split on the 1st of December 2020. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Cyduct Diagnostics to cross-verify your projections.Cyduct Diagnostics Related Hype Analysis
Having access to credible news sources related to Cyduct Diagnostics' direct competition is more important than ever and may enhance your ability to predict Cyduct Diagnostics' future price movements. Getting to know how Cyduct Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyduct Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ESMC | Escalon Medical Corp | 0.00 | 0 per month | 0.00 | (0.05) | 6.67 | (6.25) | 19.22 | |
| TBIO | Telesis Bio | (0.05) | 2 per month | 0.00 | 0.20 | 284.62 | (40.00) | 824.84 | |
| CHYPF | Health Logic Interactive | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EDXC | Endexx Corp | (0.0009) | 1 per month | 0.00 | (0.05) | 15.38 | (20.00) | 72.86 | |
| MRZM | Marizyme | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BINP | Bionoid Pharma | 0.00 | 0 per month | 13.88 | 0.11 | 34.69 | (36.36) | 176.17 | |
| EPGNF | Epigenomics AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BMMJ | Body And Mind | 0.00 | 2 per month | 19.48 | 0.05 | 48.57 | (32.31) | 121.50 | |
| LGND | Ligand Pharmaceuticals Incorporated | (0.84) | 9 per month | 1.94 | 0.02 | 3.51 | (2.76) | 18.09 | |
| PHMB | Pharmacom Biovet | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Cyduct Diagnostics
For every potential investor in Cyduct, whether a beginner or expert, Cyduct Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cyduct Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cyduct. Basic forecasting techniques help filter out the noise by identifying Cyduct Diagnostics' price trends.Cyduct Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cyduct Diagnostics pink sheet to make a market-neutral strategy. Peer analysis of Cyduct Diagnostics could also be used in its relative valuation, which is a method of valuing Cyduct Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cyduct Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Cyduct Diagnostics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyduct Diagnostics shares will generate the highest return on investment. By undertsting and applying Cyduct Diagnostics pink sheet market strength indicators, traders can identify Cyduct Diagnostics entry and exit signals to maximize returns.
Cyduct Diagnostics Risk Indicators
The analysis of Cyduct Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cyduct Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cyduct pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 14.68 | |||
| Standard Deviation | 50.15 | |||
| Variance | 2515.14 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cyduct Diagnostics
The number of cover stories for Cyduct Diagnostics depends on current market conditions and Cyduct Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cyduct Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cyduct Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Cyduct Pink Sheet Analysis
When running Cyduct Diagnostics' price analysis, check to measure Cyduct Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyduct Diagnostics is operating at the current time. Most of Cyduct Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cyduct Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyduct Diagnostics' price. Additionally, you may evaluate how the addition of Cyduct Diagnostics to your portfolios can decrease your overall portfolio volatility.